A study of the short-term gait improvement effect using a biological signal reaction type motor function improvement device in patients with Parkinson's disease.

A study of the short-term gait improvement effect using a biological signal reaction type motor function improvement device for gait instability in pati ents with Parkinson's disease. a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs052220012

Enrollment

Registered

2022-04-22

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease Parkinson's disease

Interventions

The normal rehabilitation group and the HAL grou p are assigned 1: 1 and the normal rehabilitation g roup is subjected to normal walking training, and t he HAL group is subjected to walking training b

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Those who have been diagnosed with clinically established or clinically probable cases according to the clinical diagnostic criteria for Parkinson's disease by the Movement Disorder Society (MDS). 2)Hoehn-Yahr Scale stage III 3)Those who have not changed the type and dos e of Parkinson's drug before 4 weeks of the date o f consent acquisition and have no plans to change it while participating in clinical research. 4)Those who do not have a clear wearing-off phe nomenon. 5)Those who are judged by the doctor that their g eneral condition is stable and that standing / walki ng training can be carried out. 6)Those who can stand up and sit and walk 10 m or more without assistance (regardless of the use of assistive devices). 7)Those who are 20 years old or older at the time of consent 8)Those who have obtained the document conse nt of the subject. 9)Those who meet the following conditions descri bed in the HAL package insert a)Weight 40-100kg b)Those who can wear HAL with a height of about 150 to 190 cm or a body size such as thigh length, lower leg length, and waist width. 10) Those who can about21-day rehabilitation hos pitalization for PD.

Exclusion criteria

Exclusion criteria: 1)Those who the doctor judges to be inappropriat e, such as improper standing and walking training 2)Those who have difficulty wearing HAL due to p hysical deformation, etc. 3)Those who have difficulty in attaching electrode s due to skin diseases, etc. 4)Those who are pregnant 5)Those who have a cognitive function test (MMS E) of 23 points or less. 6)In addition, those who are judged to be inappro priate for conducting this research by the principal investigator or the other investigator.

Design outcomes

Primary

Measure	Time frame
2 minutes walking distance	—

Secondary

Measure	Time frame
10m walking time Walking speed Walking rate Stride SPPB ADL FIM UPRDS Part 3 ESAS GSES Posture tilt of body axis Timed Up and Go Test TUG	—

Contacts

Public ContactUtako Shirono

Kobe City Medical Center General Hospital

ushirono@kcho.jp+81-78-302-4321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026